Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$848M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$631M |
| 3 |
Truist Financial
TFC
|
+$445M |
| 4 |
Amazon
AMZN
|
+$334M |
| 5 |
ServiceNow
NOW
|
+$251M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.15B |
| 2 |
STI
SunTrust Banks, Inc.
STI
|
+$466M |
| 3 |
VIAB
Viacom Inc. Class B
VIAB
|
+$139M |
| 4 |
Oracle
ORCL
|
+$136M |
| 5 |
Intuitive Surgical
ISRG
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.79% |
| 2 | Financials | 15.45% |
| 3 | Healthcare | 13.87% |
| 4 | Consumer Discretionary | 9.9% |
| 5 | Industrials | 9.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3101
Lineage Cell Therapeutics
LCTX
$278M
| $1.4M | ﹤0.01% |
1,568,727
+27,939
| +2% | +$23.3K |
|
|
BCEL
3102
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $1.4M | ﹤0.01% |
90,242
+45,086
| +100% | +$544K |
|
3103
Exicure
XCUR
$8.29M
| $1.39M | ﹤0.01% |
3,231
+722
| +29% | +$295K |
|
3104
Cytosorbents Corp
CTSO
$23.3M
| $1.38M | ﹤0.01% |
359,652
+6,891
| +2% | +$30.1K |
|
3105
Exagen
XGN
$160M
| $1.38M | ﹤0.01% |
+54,432
| New | +$968K |
|
|
LJPC
3106
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $1.38M | ﹤0.01% |
350,261
+8,581
| +3% | +$50.7K |
|
|
NESR
3107
National Energy Services Reunited Corp
NESR
$3.51B
| $1.37M | ﹤0.01% |
150,271
+23,406
| +18% | +$181K |
|
3108
Enel Chile
ENIC
$6.05B
| $1.37M | ﹤0.01% |
288,379
+69,093
| +32% | +$298K |
|
|
PBPB
3109
DELISTED
Potbelly
PBPB
| $1.36M | ﹤0.01% |
322,992
+14,721
| +5% | +$64.3K |
|
3110
CB Financial Services
CBFV
$192M
| $1.36M | ﹤0.01% |
45,164
+251
| +0.6% | +$7.13K |
|
3111
Orion Group Holdings
ORN
$402M
| $1.36M | ﹤0.01% |
262,061
-1,720
| -0.7% | -$8.53K |
|
|
MPX
3112
DELISTED
Marine Products Corp
MPX
| $1.35M | ﹤0.01% |
94,125
+1,592
| +2% | +$23K |
|
|
GSB
3113
DELISTED
GlobalSCAPE, Inc.
GSB
| $1.35M | ﹤0.01% |
137,659
-11,117
| -7% | -$120K |
|
|
ENZ
3114
DELISTED
Enzo Biochem, Inc.
ENZ
| $1.35M | ﹤0.01% |
513,792
+2,927
| +0.6% | +$8.74K |
|
|
SHSP
3115
DELISTED
SharpSpring, Inc.
SHSP
| $1.34M | ﹤0.01% |
116,492
+7,111
| +7% | +$72.4K |
|
|
IAE
3116
Voya Asia Pacific High Dividend Equity Income Fund
IAE
$93.7M
| $1.33M | ﹤0.01% |
156,956
+58,310
| +59% | +$485K |
|
3117
GSI Technology
GSIT
$255M
| $1.33M | ﹤0.01% |
187,072
+2,320
| +1% | +$17.5K |
|
|
SRT
3118
DELISTED
Startek Inc.
SRT
| $1.32M | ﹤0.01% |
166,165
+3,561
| +2% | +$26K |
|
3119
Twin Disc
TWIN
$355M
| $1.32M | ﹤0.01% |
119,741
+2,678
| +2% | +$28K |
|
|
EMWP
3120
DELISTED
Eros Media World PLC
EMWP
| $1.31M | ﹤0.01% |
19,362
-177
| -0.9% | -$8.26K |
|
|
BLDP
3121
Ballard Power Systems
BLDP
$790M
| $1.31M | ﹤0.01% |
183,454
+2,802
| +2% | +$17.1K |
|
|
UBFO
3122
DELISTED
United Security Bancshares
UBFO
| $1.3M | ﹤0.01% |
121,500
+278
| +0.2% | +$2.89K |
|
3123
PLDT
PHI
$4.24B
| $1.3M | ﹤0.01% |
+65,145
| New | +$1.36M |
|
3124
Avalo Therapeutics
AVTX
$1.05B
| $1.3M | ﹤0.01% |
84
+1
| +1% | +$10.5K |
|
3125
Global Water Resources
GWRS
$219M
| $1.29M | ﹤0.01% |
98,531
-656
| -0.7% | -$8.23K |
|
Similar funds
Geode Capital Management's Q4 2019 Portfolio in Review
As of Q4 2019, Geode Capital Management held 4,322 positions worth $478B, up 12% from $428B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Geode Capital Management's Q4 2019 filing shows 132 new, 3,091 increased, 523 reduced and 113 closed positions. Its largest new stake was Apollo Global Management: 1,482,213 shares worth $70.7M. The largest sale was Celgene Corp, an estimated $1.15B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q4 2019 buy was Apollo Global Management: 1,482,213 shares worth $70.7M.
- Geode Capital Management added most to Microsoft in Q4 2019, an estimated $848M increase.
- Geode Capital Management's biggest Q4 2019 reduction was Oracle, cutting an estimated $136M.
- Geode Capital Management fully exited Celgene Corp in Q4 2019, selling an estimated $1.15B.
- Geode Capital Management's ten largest holdings make up 19% of its $478B portfolio in Q4 2019.
- Geode Capital Management opened 132 new positions and closed 113 in Q4 2019.
- Geode Capital Management's portfolio value rose 12% quarter-over-quarter to $478B.
Based on Geode Capital Management's 13F filing for Q4 2019, filed 13 Feb 2020.